UniQure (QURE) Stock Drop Looms as FDA Concern Over Huntington’s Data Spurs Mizuho Downgrade and Delayed Launch

In other news, earlier in its Q3 2025 earnings report, UniQure detailed promising clinical data for its lead gene therapy ...

ORIC Pharmaceuticals (ORIC) Surges as Intriguing ESMO Asia Data for Enozertinib Prompts Wells Fargo to Assign Higher Value

ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) is a clinical-stage biopharmaceutical company that discovers and develops therapies ...

Aurora Innovation, Detmar Logistics Partner to Deploy Autonomous Trucks for 24/7 Frac Sand Hauling in Permian Basin

Aurora Innovation Inc. (NASDAQ: AUR) is one of the stocks that will double in 2026. On December 9, Itay Michaeli from TD ...

Mizuho Cuts Evolus (EOLS) Estimates for Jeuveau/Evolysse on Waning Consumer Sentiment and Inflationary Pressure on Elective Aesthetics

Earlier in its Q3 2025 earnings report, Evolus achieved global net revenue of $69 million, which marked a 13% increase ...

Sarepta’s Elevidys Safety Concerns Open Major Opportunity for Solid Biosciences’ (SLDB) SGT-003 in Duchenne Therapy

Solid Biosciences Inc. (NASDAQ:SLDB) develops therapies for neuromuscular and cardiac diseases in the US. In addition, the ...

Gogo (GOGO) Faces Triple Threat: Elevated Debt, Strained ATG Adds, Intensifying Starlink Competition in Commercial Aviation

In Q3 2025, Gogo announced that the company shipped a record 437 Air-to-Ground/ATG units in the quarter, signaling strong ...

Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership

Evolent Health Inc. (NYSE: EVH) is one of the stocks that will double in 2026. On November 21, Citi lowered the firm’s price ...

Bitfarms (BITF) Stock Deserves Higher Multiple as Q3 Earnings Show Strategic Pivot to High-Margin AI Energy Facilities

In its Q3 2025 earnings report, Bitfarms highlighted significant progress in transitioning from Bitcoin mining to becoming a ...